Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
Journal of Cancer Research and Clinical Oncology
|
December 11, 2008
Sodium valproate, a histone deacetylase inhibitor, decreases the secretion of soluble Fas by human osteosarcoma cells and increases their sensitivity to Fas-mediated cell death
Koji Yamanegi, Junko Yamane, Masaki Hata, et al.
Oncology Reports
|
August 28, 2012
Downregulation of matrix metalloproteinase-9 mRNA by valproic acid plays a role in inhibiting the shedding of MHC class I-related molecules A and B on the surface of human osteosarcoma cells
Koji Yamanegi, Junko Yamane, Kenta Kobayashi, et al.
In Vivo (Athens, Greece)
|
June 27, 2023
Clinical Utility of Bland Embolization Using Microspheres for Painful Malignant Musculoskeletal Tumors
Junichi Taniguchi, Haruyuki Takaki, Hiroshi Kodama, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
March 24, 2004
Inhibition by interleukin-18 of the growth of Dunn osteosarcoma cells
Takuya Okamoto, Naoko Yamada, Tohru Tsujimura, et al.
International Journal of Oncology
|
May 12, 2012
Valproic acid cooperates with hydralazine to augment the susceptibility of human osteosarcoma cells to Fas- and NK cell-mediated cell death
Koji Yamanegi, Junko Yamane, Kenta Kobayashi, et al.
Clinical Orthopaedics and Related Research
|
April 17, 2020
What Factors Are Associated with Treatment Outcomes of Japanese Patients with Clear Cell Chondrosarcoma?
Robert Nakayama, Keiko Hayakawa, Eisuke Kobayashi, et al.
Oncology Reports
|
November 3, 2010
Sodium valproate, a histone deacetylase inhibitor, augments the expression of cell-surface NKG2D ligands, MICA/B, without increasing their soluble forms to enhance susceptibility of human osteosarcoma cells to NK cell-mediated cytotoxicity
Koji Yamanegi, Junko Yamane, Kenta Kobayashi, et al.
Cancer Science
|
October 24, 2007
Enhanced suppression of pulmonary metastasis of malignant melanoma cells by combined administration of alpha-galactosylceramide and interleukin-18
Shoji Nishio, Naoko Yamada, Hideki Ohyama, et al.
Pathology International
|
July 2, 2015
Primary central chondrosarcoma of long bone, limb girdle and trunk: Analysis of 174 cases by numerical scoring on histology
Eiichi Konishi, Yasuaki Nakashima, Masayuki Mano, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
Journal of Cancer Research and Clinical Oncology
|
December 11, 2008
Sodium valproate, a histone deacetylase inhibitor, decreases the secretion of soluble Fas by human osteosarcoma cells and increases their sensitivity to Fas-mediated cell death
Koji Yamanegi, Junko Yamane, Masaki Hata, et al.
Oncology Reports
|
August 28, 2012
Downregulation of matrix metalloproteinase-9 mRNA by valproic acid plays a role in inhibiting the shedding of MHC class I-related molecules A and B on the surface of human osteosarcoma cells
Koji Yamanegi, Junko Yamane, Kenta Kobayashi, et al.
In Vivo (Athens, Greece)
|
June 27, 2023
Clinical Utility of Bland Embolization Using Microspheres for Painful Malignant Musculoskeletal Tumors
Junichi Taniguchi, Haruyuki Takaki, Hiroshi Kodama, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
March 24, 2004
Inhibition by interleukin-18 of the growth of Dunn osteosarcoma cells
Takuya Okamoto, Naoko Yamada, Tohru Tsujimura, et al.
International Journal of Oncology
|
May 12, 2012
Valproic acid cooperates with hydralazine to augment the susceptibility of human osteosarcoma cells to Fas- and NK cell-mediated cell death
Koji Yamanegi, Junko Yamane, Kenta Kobayashi, et al.
Clinical Orthopaedics and Related Research
|
April 17, 2020
What Factors Are Associated with Treatment Outcomes of Japanese Patients with Clear Cell Chondrosarcoma?
Robert Nakayama, Keiko Hayakawa, Eisuke Kobayashi, et al.
Oncology Reports
|
November 3, 2010
Sodium valproate, a histone deacetylase inhibitor, augments the expression of cell-surface NKG2D ligands, MICA/B, without increasing their soluble forms to enhance susceptibility of human osteosarcoma cells to NK cell-mediated cytotoxicity
Koji Yamanegi, Junko Yamane, Kenta Kobayashi, et al.
Cancer Science
|
October 24, 2007
Enhanced suppression of pulmonary metastasis of malignant melanoma cells by combined administration of alpha-galactosylceramide and interleukin-18
Shoji Nishio, Naoko Yamada, Hideki Ohyama, et al.
Pathology International
|
July 2, 2015
Primary central chondrosarcoma of long bone, limb girdle and trunk: Analysis of 174 cases by numerical scoring on histology
Eiichi Konishi, Yasuaki Nakashima, Masayuki Mano, et al.
Page
of 5